Adoptive immunotherapy in patients with recurrent malignant glioma: preliminary results of using autologous whole-tumor vaccine plus granulocyte-macrophage colony-stimulating factor and adoptive transfer of anti-CD3-activated lymphocytes.

Neurosurgical focus

Volumn 9, Issue 6, 2000, Pages

  Sloan, A E ^a   Dansey, R ^a   Zamorano, L ^a   Barger, G ^a   Hamm, C ^a   Diaz, F ^a   Baynes, R ^a   Wood, G ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CD3 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; FEMALE; GLIOMA; HUMAN; IMMUNOLOGY; LEUKAPHERESIS; LYMPHOCYTE ACTIVATION; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIGENS, CD3; BRAIN NEOPLASMS; CANCER VACCINES; FEMALE; GLIOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKAPHERESIS; LYMPHOCYTE ACTIVATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; T-LYMPHOCYTES; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 33746816721     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/foc.2000.9.6.10     Document Type: Article

References (0)